Abstract: A system and method for mind-body relaxation may include a plurality of vibration modules, a light-providing member, a controller, a relaxation substrate, a pillow member, a graphical user interface (GUI), and network connection circuitry.

Abstract: A method and system for delivering drug includes a first set of holes filled with a first formulation of the drug and a second set of holes filled with a second formulation of the same drug. This dual formulation or dual release kinetic system allows the creation of specifically tailored release kinetics by summation of multiple release kinetics.

Abstract: Implantable medical devices may be utilized to locally delivery one or more drugs or therapeutic agents to treat a wide variety of conditions, including the treatment of the biological organism's reaction to the introduction of the implantable medical device. These therapeutic agents may be released under controlled and directional conditions from a stent so that the one or more therapeutic agents reach the correct target area, for example, the surrounding tissue.

Abstract: An implantable drug delivery device loaded with a beneficial agent is provided, wherein the beneficial agent is in two different forms, a first form having a higher solubility and a second form having a lower solubility, and wherein the two different forms are present in a proportion which is selected to achieve a desired release rate.

Abstract: An electrically programmable fuse controller, a method of controlling a drive voltage of an integrated circuit (IC) and an IC incorporating the controller or the method. In one embodiment, the controller includes a VID eFuse controller configured to receive and write a voltage identifier to an associated eFuse and thereafter allow the voltage identifier to be read from the eFuse and employed to set a drive voltage of an integrated circuit associated with the VID eFuse controller.

Abstract: Implantable medical devices may be utilized to locally delivery one or more drugs or therapeutic agents to treat a wide variety of conditions, including the treatment of the biological organism's reaction to the introduction of the implantable medical device. These therapeutic agents may be released under controlled and directional conditions from a stent so that the one or more therapeutic agents reach the correct target area, for example, the surrounding tissue.

Abstract: An implantable drug delivery device loaded with a beneficial agent is provided, wherein the beneficial agent is in two different forms, a first form having a higher solubility and a second form having a lower solubility, and wherein the two different forms are present in a proportion which is selected to achieve a desired release rate.

Abstract: Implantable medical devices may be utilized to locally delivery one or more drugs or therapeutic agents to treat a wide variety of conditions, including the treatment of the biological organism's reaction to the introduction of the implantable medical device. These therapeutic agents may be released under controlled and directional conditions from a stent so that the one or more therapeutic agents reach the correct target area, for example, the surrounding tissue.

Abstract: A test system tests a circuit. Compressed scan data subsets are stored, one at a time, in a memory of the test system. The multiple compressed scan data subsets correspond with multiple scan chains in a function block of the tested circuit. Transmission of the compressed scan data subset from the memory to the tested circuit is controlled by the test system. The test system receives a compacted test output subset from the tested circuit and provides a test system output that indicates a presence of any errors in functioning of the tested circuit.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a cylinder having a first diameter to a cylinder having a second diameter. A plurality of different beneficial agents can be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different beneficial agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different beneficial agents may also be used to address different diseases, such as restenosis and acute myocardial infarction from the same drug delivery device.

Abstract: A clock pulse controller includes a test clock pulse input for receiving test clock pulses. A scan enable input receives a scan enable signal having a first state and a second state. A trigger pulse input receives a trigger pulse. A clock pulse output generates a launch clock pulse and a capture clock pulse from the test clock pulses immediately after receiving a predetermined number of the test clock pulses immediately following the trigger pulse. A delayed scan enable output generates a delayed scan enable signal that transitions from the first state to the second state between a leading edge of the launch clock pulse and a leading edge of the capture clock pulse.

Abstract: Methods and devices are provided for the delivery of therapeutic agents which reduce myocardial tissue damage due to ischemia and anti-restenotic agents which inhibit restenosis following a cardiac procedure such as stent implantation. The anti-ischemia agents are delivered to the myocardial tissue over an administration period sufficient to achieve reduction in ischemic or reperfusion injury of the myocardial tissue. The anti-restenotic agents are delivered over an administration period sufficient to reduce the re-narrowing of a blood vessel following a cardiac procedure such as implantation of a device. Preferred anti-restenotic drugs are those that do not reduce the beneficial effects provided by the anti-ischemic drug, such as drugs that do not act on the mammalian target of rapamycin (mTOR).

Abstract: A clock pulse controller includes a test clock pulse input for receiving test clock pulses. A scan enable input receives a scan enable signal having a first state and a second state. A trigger pulse input receives a trigger pulse. A clock pulse output generates a launch clock pulse and a capture clock pulse from the test clock pulses immediately after receiving a predetermined number of the test clock pulses immediately following the trigger pulse. A delayed scan enable output generates a delayed scan enable signal that transitions from the first state to the second state between a leading edge of the launch clock pulse and a leading edge of the capture clock pulse.

Abstract: A test system tests a circuit. Compressed scan data subsets are stored, one at a time, in a memory of the test system. The multiple compressed scan data subsets correspond with multiple scan chains in a function block of the tested circuit. Transmission of the compressed scan data subset from the memory to the tested circuit is controlled by the test system. The test system receives a compacted test pattern subset from the tested circuit and provides a test system output that indicates a presence of any errors in functioning of the tested circuit.

Abstract: An implantable drug delivery system uses a hydrophobic compound as an outer layer or barrier for retarding release of water soluble drugs from the implantable system. The system includes an inner portion of a water soluble drug in a drug matrix material which stabilizes the drug. An outer portion of the drug delivery system separates the inner portion from a surrounding environment. The outer portion retards the release of the water soluble drug from the inner portion. The outer portion includes a hydrophobic non-polymer compound and a binder. The hydrophobic compound can be another drug which can be delivered at an entirely different release kinetic from the water soluble drug and for treatment of the same or a different condition. When the drug delivery system is implanted in a body the outer portion retards the release of the water soluble drug by controlling fluid passing from the body into the inner portion and by controlling passage of the water soluble drug from the inner portion into the body.

Abstract: A radio frequency switch includes a field-effect-transistor (FET) having a gate connected to a voltage multiplier. The control voltage for the switch is delivered to the voltage multiplier which delivers an increased gate voltage to turn the switch on. The voltage multiplier is driven by fluctuations of the control voltage as a transceiver, for example, is switched from the transmit to the receive mode.

Abstract: A method is provided for applying a coating to an ophthalmic device by applying a coating to a face of the mold used to make the device and partially curing the coating, or, if the viscosity is sufficiently high, leaving the coating uncured. Then the liquid used to form the lens is poured into the mold and the liquid and coating are concurrently cured.

Abstract: A radio frequency switch includes a field-effect-transistor (FET) having a gate connected to a voltage multiplier. The control voltage for the switch is delivered to the voltage multiplier which delivers an increased gate voltage to turn the switch on. The voltage multiplier is driven by fluctuations of the control voltage as a transceiver, for example, is switched from the transmit to the receive mode.

Abstract: A driver circuit for a laser diode includes a prebiasing amplifier for providing a prebiasing current, a second amplifier for amplifying an input signal to provide an output current signal, and a third amplifier for amplifying the sum of the current output signal and the prebiasing current. In one embodiment, the third amplifier includes first and second current mirrors. In another embodiment, a capacitor couples one output of the second amplifier to an inverting input of the third amplifier, so as to increase the effective gain of the third amplifier.